The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

About 71% of U.S. adults are either overweight or obese, according to the Centers for Disease Control. That makes it easy to see why there’s currently such ...

A tiny but crucial agency that maintains physical coordinates like latitude and longitude in the US is struggling as the ...

For weight loss, weight management, and overall wellness, focus on eating healthy foods, like high-protein meals, legumes, ...

A new head-to-head study reveals tirzepatide achieves 47% more weight loss than semaglutide in people with obesity but without diabetes, highlighting its superior effectiveness and cardiometabolic ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

The FDA has approved medications like Zepbound and Wegovy for weight loss, which use the same active ingredient as the ...

SaveHealth explores the historical trajectory of weight loss drugs, examining their scientific basis, regulatory battles, ...

GLP-1 weight loss drugs like Ozempic and Wegovy are being hailed as game-changers, but are they really safe, effective, or ...

Omada Health is launching new AI tools for nutrition care after filing its S-1 to go public.